E. Klein
- Immunology top 10%
- Immune Cell Function and Interaction 12
- Immunotherapy and Immune Responses 12
- T-cell and B-cell Immunology 7
-
- Cancer Immunotherapy and Biomarkers 2
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Sarcoma Diagnosis and Treatment 3
-
- Chronic Lymphocytic Leukemia Research 2
-
- Cardiac tumors and thrombi 2
- Co-authors
- Farkas VánkyFrancisco Ruiz‐CabelloFederico GarridoMaria G. MasucciMikael JondalJun MinowadaM. FoppGiuseppe Masucci
- Cited by
- ImmunologyHematologyOncology
- Journals
- Surgical Oncology (2 papers)Immunology Letters (2 papers)Experimental Cell Research (2 papers)
- Partner nations
- SwedenUnited StatesIsrael
In The Last Decade
E. Klein
25 papers receiving 334 citations
Peers
Comparison fields: 5 of 62
- Immunology 226
- Hematology 43
- Oncology 104
- Radiology, Nuclear Medicine and Imaging 50
- Biotechnology 15
Countries citing papers authored by E. Klein
This map shows the geographic impact of E. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Klein more than expected).
Fields of papers citing papers by E. Klein
This network shows the impact of papers produced by E. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Klein. The network helps show where E. Klein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 1992 | 24 | |
| 5 | 1991 | 49 | |
| 6 | Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines. | 1991 | 9 |
| 7 | 1991 | 1 | |
| 8 | Polysaccharides from chilean seaweeds. Part xiii studies on the carrageenan from gigartina papillata j. Ag | 1983 | 2 |
| 9 | Natural killer and tumor recognizing lymphocyte activity in tumor patients. | 1980 | 3 |
| 10 | 1979 | 2 | |
| 11 | 1978 | 35 | |
| 12 | Functional studies on tumor-infiltrating lymphocytes in man. | 1977 | 10 |
| 13 | 1977 | 57 | |
| 14 | 1977 | 4 | |
| 15 | 1976 | 35 | |
| 16 | 1975 | 26 | |
| 17 | 1972 | 4 | |
| 18 | 1971 | 12 | |
| 19 | 1971 | 19 | |
| 20 | [Differential diagnosis of unusual spinal changes]. | 1957 | 3 |
About E. Klein
E. Klein is a scholar working on Immunology, Oncology, Virology, Genetics and Hematology, having authored 26 papers that have together received 373 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (7 papers), Sarcoma Diagnosis and Treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cardiac tumors and thrombi (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Immunology (226 citations), Hematology (43 citations), Oncology (104 citations), Radiology, Nuclear Medicine and Imaging (50 citations) and Biotechnology (15 citations). E. Klein has collaborated with scholars based in Sweden, United States and Israel. Frequent co-authors include Farkas Vánky, Francisco Ruiz‐Cabello, Federico Garrido, Maria G. Masucci, Mikael Jondal, Jun Minowada, M. Fopp, Giuseppe Masucci, W. Berthold and H. Neumann. Their work appears in journals such as Surgical Oncology, Immunology Letters, Experimental Cell Research, Proceedings of the National Academy of Sciences and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.